The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptase. 1993

J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
Division of Virology, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.

The (-) enantiomer of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine is a potent inhibitor of human immunodeficiency virus type 1 in vitro. The 5'-triphosphates of the (-) and (+) enantiomers equally inhibited the production of full-length minus-strand DNA in an endogenous reverse transcriptase reaction, each competitively inhibited DNA synthesis, and each was used as a chain-terminating substrate.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D003570 Cytidine Triphosphate Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. CTP,CRPPP,Magnesium CTP,Mg CTP,Triphosphate, Cytidine
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D000068679 Emtricitabine A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS. Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,Coviracil,Emtriva,Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016047 Zalcitabine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. 2',3'-Dideoxycytidine,Dideoxycytidine,ddC (Antiviral),HIVID Roche,Hivid,NSC-606170,2',3' Dideoxycytidine,NSC 606170,NSC606170

Related Publications

J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
November 1992, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
December 1992, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
February 1996, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
February 1996, Xenobiotica; the fate of foreign compounds in biological systems,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
October 1991, The Journal of biological chemistry,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
October 1997, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
November 1993, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
June 1994, Antimicrobial agents and chemotherapy,
J E Wilson, and J L Martin, and K Borroto-Esoda, and S Hopkins, and G Painter, and D C Liotta, and P A Furman
March 1994, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!